Q2 Earnings Outlook For Chemours

On Thursday, August 1, Chemours CC will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Earnings and Revenue

Wall Street analysts see Chemours reporting earnings of 86 cents per share on sales of $1.50 billion.

Chemours earnings in the same period a year ago was $1.71. Quarterly sales came in at $1.82 billion. The analyst consensus estimate would represent a 49.71% decrease in the company's earnings. Revenue would have fallen 17.40% from the same quarter last year. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Stock Performance

Over the last 52-week period, shares are down 57.28%. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release. Analyst estimates have adjusted lower for EPS and revenues over the past 90 days. Analysts have been rating Chemours stock as Neutral. The strength of this rating has maintained conviction over the past three months.